The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
The Awards recognizes standout digital health & medical technology products and companies
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
New agreement applies to the polymers of the Medical Care series portfolio
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
